BioLargo Debt to Equity Ratio 2010-2024 | BLGO
Current and historical debt to equity ratio values for BioLargo (BLGO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. BioLargo debt/equity for the three months ending September 30, 2024 was 0.03.
BioLargo Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2024-09-30 |
$0.00B |
$0.01B |
0.72 |
2024-06-30 |
$0.00B |
$0.01B |
0.71 |
2024-03-31 |
$0.01B |
$0.01B |
0.91 |
2023-12-31 |
$0.00B |
$0.00B |
0.95 |
2023-09-30 |
$0.00B |
$0.00B |
0.72 |
2023-06-30 |
$0.00B |
$0.00B |
0.62 |
2023-03-31 |
$0.00B |
$0.00B |
0.87 |
2022-12-31 |
$0.00B |
$0.00B |
1.42 |
2022-09-30 |
$0.00B |
$0.00B |
1.15 |
2022-06-30 |
$0.00B |
$0.00B |
1.43 |
2022-03-31 |
$0.00B |
$0.00B |
1.35 |
2021-12-31 |
$0.00B |
$0.00B |
2.24 |
2021-09-30 |
$0.00B |
$0.00B |
4.27 |
2021-06-30 |
$0.00B |
$0.00B |
3.42 |
2021-03-31 |
$0.01B |
$0.00B |
5.91 |
2020-12-31 |
$0.01B |
$0.00B |
-22.03 |
2020-09-30 |
$0.01B |
$0.00B |
9.81 |
2020-06-30 |
$0.01B |
$-0.00B |
-4.05 |
2020-03-31 |
$0.01B |
$-0.00B |
-2.35 |
2019-12-31 |
$0.01B |
$-0.00B |
-2.66 |
2019-09-30 |
$0.01B |
$-0.00B |
-6.05 |
2019-06-30 |
$0.01B |
$-0.00B |
-2.87 |
2019-03-31 |
$0.01B |
$-0.00B |
-2.89 |
2018-12-31 |
$0.00B |
$-0.00B |
-3.84 |
2018-09-30 |
$0.00B |
$-0.00B |
-2.11 |
2018-06-30 |
$0.00B |
$-0.00B |
-2.81 |
2018-03-31 |
$0.01B |
$-0.01B |
-1.32 |
2017-12-31 |
$0.01B |
$-0.00B |
-1.44 |
2017-09-30 |
$0.00B |
$-0.00B |
-1.73 |
2017-06-30 |
$0.00B |
$-0.00B |
-1.19 |
2017-03-31 |
$0.00B |
$-0.00B |
-1.92 |
2016-12-31 |
$0.00B |
$-0.00B |
-3.74 |
2016-09-30 |
$0.00B |
$0.00B |
-13.29 |
2016-06-30 |
$0.00B |
$0.00B |
-3.39 |
2016-03-31 |
$0.00B |
$0.00B |
4.47 |
2015-12-31 |
$0.00B |
$0.00B |
0.67 |
2015-09-30 |
$0.00B |
$0.00B |
1.99 |
2015-06-30 |
$0.00B |
$0.00B |
-1.54 |
2015-03-31 |
$0.00B |
$0.00B |
-1.93 |
2014-12-31 |
$0.00B |
$0.00B |
-1.66 |
2014-09-30 |
$0.00B |
$0.00B |
-1.91 |
2014-06-30 |
$0.00B |
$0.00B |
-8.78 |
2014-03-31 |
$0.00B |
$0.00B |
-21.29 |
2013-12-31 |
$0.00B |
$-0.00B |
-1.30 |
2013-09-30 |
$0.00B |
$0.00B |
-1.38 |
2013-06-30 |
$0.00B |
$-0.00B |
-1.30 |
2013-03-31 |
$0.00B |
$0.00B |
-1.42 |
2012-12-31 |
$0.00B |
$0.00B |
-1.93 |
2012-09-30 |
$0.00B |
$-0.00B |
-1.52 |
2012-06-30 |
$0.00B |
$-0.00B |
-1.68 |
2012-03-31 |
$0.00B |
$-0.00B |
-1.26 |
2011-12-31 |
$0.00B |
$-0.00B |
-1.16 |
2011-09-30 |
$0.00B |
$-0.00B |
-1.13 |
2011-06-30 |
$0.00B |
$-0.00B |
-1.16 |
2011-03-31 |
$0.00B |
$-0.00B |
-1.41 |
2010-12-31 |
$0.00B |
$-0.00B |
-1.18 |
2010-09-30 |
$0.00B |
$-0.00B |
-1.09 |
2010-06-30 |
$0.00B |
$-0.00B |
-1.03 |
2010-03-31 |
$0.01B |
$-0.01B |
-1.04 |
2009-12-31 |
$0.00B |
$-0.00B |
-1.05 |
2009-09-30 |
$0.00B |
$0.01B |
0.79 |
2009-06-30 |
$0.00B |
$0.01B |
0.55 |
2009-03-31 |
$0.00B |
$0.01B |
0.61 |
Sector |
Industry |
Market Cap |
Revenue |
Construction |
Engineering - Research & Development Services |
$0.054B |
$0.012B |
BioLargo Inc. is a cleantech and life sciences innovator and engineering services solution provider. The company's core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs. BioLargo Inc. is based in WESTMINSTER, CA.
|